Osteoporosis may be defined as the loss of bone accelerated beyond the normal "physiological" rates, although this begs the question of what normal loss might be. The condition is common either in idiopathic form or as a complication of other diseases. Early diagnosis is difficult because osteoporosis is asymptomatic until it has advanced far enough to cause structural failure of bone. Its recognition, measurement, prevention, and treatment were discussed at a recent symposium and the account of this emphasises how opinion on these issues is still divided. 1 Most adults lose minerals from bone steadily throughout their life. In women this bone loss is accelerated for a year or two after the menopause, after which the decline slows to the previous rate, so that bone mass may ultimately be less than half of that in a young adult. But osteoporosis is not inevitable, and some people do not lose bone.2 Management of osteoporosis is centred on treating the structural failure-that is, the fracture or episode of back pain which brings the patient to his doctor-the primary prevention of osteoporosis in those at risk, and the secondary prevention in those who have already sustained a fracture.
Osteoporotic fractures heal normally, so there is little place for treatment aimed at speeding up this process, unless a deficiency such as scurvy or lack of protein or of vitamin D is also suspected. Fractures of long bones require fixation according to standard orthopaedic principles, but orthopaedic surgeons disagree on how to treat a recent osteoporotic crush fracture of a vertebral body. Most surgeons use simple analgesics and advocate a short period of bed rest. Some prescribe a spinal brace but others would never do so, and opinion is also divided whether calcium supplements and anabolic steroids should be given. -a figure which many nutritionists would still regard as low. The group as a whole was in negative calcium balance, possibly owing to the high protein content of Western diets, which leads to the production of an acid urine.14 15 Osteoporosis thus appears to join diabetes, gall stones, and diverticulosis as one of the diseases of affluence. The higher the calcium intake, the less negative the calcium balance. The fashion for increased dietary bran and the consumption of unleavened bread and unpolished rice with their phytic acid content intact may also increase the loss of calcium. Studies now suggest that an intake of at least 1 5 g a day after the menopause and 1 g a day before the menopause is necessary to maintain calcium equilibrium in women. Hence calcium seems to be the forgotten nutrient of Western society, and it seems that a failure to consume enough of it must inevitably lead to loss of bone mineral.
All forms of calcium are absorbed well, though the gut probably rejects an excess if the plasma concentrations are high. Cheap finely powdered calcium carbonate, which is readily available, has the advantage of an antacid effect in the stomach but the disadvantage of producing carbon dioxide and of interfering with digestion; soluble calcium gluconate is similar but more palatable. Windsor and colleagues '6 have shown that the calcium in whole bone extract (microcrystalline hydroxyapatite compound) is well absorbed and does not have the disadvantages of the former preparations. Microcrystalline hydroxyapatite compound contains the bone minerals calcium and phosphate together with trace amounts of magnesium and fluoride in the normal physiological proportions. Microcrystalline hydroxyapatite compound has been tried in two controlled trials in groups at risk of developing osteoporosis. Nilsen and coworkers found that patients with rheumatoid arthritis having corticosteroid treatment were protected from the usual accelerated loss of bone. '7 Epstein and colleagues'8 studied 65 postmenopausal women with primary biliary cirrhosis, excluding any contribution to bone weakness by osteomalacia by giving vitamin D. Such patients always have osteoporosis and were randomly allocated to a no treatment group or treatment with supplements of calcium gluconate or microcrystalline hydroxyapatite compound. The untreated group continued to show accelerated loss of bone, as judged by the thickness of the cortex. Calcium gluconate halted the bone loss but did not restore it, whereas microcrystalline hydroxyapatite compound did restore bone.
Sodium fluoride was first used in the treatment of osteoporosis by Rich and Ensinck in 1961.19 It improved the mineralisation of bone but did not reduce the number of bone fractures. The latter was achieved, however, once it was realised that fluoride also induces osteomalacia which can be counteracted by simultaneous treatment with calcium supplements. According to Hansson Thus in preventing osteoporosis most attention should be focused on dietary calcium. Those who consume a diet with a relatively high protein content and those who eat a diet high in fibre should balance this with an increase in dietary calcium. A calcium and fluoride regimen can restore mineral to osteoporotic bones but should probably be reserved for those who have relatively severe osteoporosis or who have already sustained fractures. Vitamin D is not needed except in those patients who also have osteomalacia, which should be proved by bone biopsy or by radionuclide bone scans.2' Nothing can restore the spinal posture to normal in those people whose spines have already shrunk because of osteoporosis. There is, however, now good evidence to suggest that preventive treatment is very effective. Perhaps the elderly hunchback whose dorsal spine radiograph seems to show more calcium in the aorta than in the spine will become a clinical curio of the past. But this will be achieved only by health education and an alteration in dietary habits. Sheila Sherlock has suggested that government action to fortify common foods may be the best way to ensure that our population achieves an adequate intake of calcium.
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